Your perspective on quiet quitting is probably generational, says one Houston expert and startup founder. Photo via Getty Images

This month, the internet has been discussing "quiet quitting," the practice of employees setting hard boundaries about when they work and to what extent they are willing to go beyond the outlined expectations of their jobs.

The conversation around quiet quitting has also been lively at the Ampersand offices. As a training company that is dedicated to training new professionals for employers both big and small, it's critically important for our team to have a good grasp on the relationship employees have with their jobs, and what motivates them to succeed. So we had a long meeting where we discussed what quiet quitting meant to each of us.

My team's take on quiet quitting

When I first read about quiet quitting, I was surprised. I started my career in New York City during the Great Recession. I was just grateful to have a job, and I was immersed in the hustle culture of NYC, working long hours to prove my value. I made a habit of getting up early and staying late during a formative time in my career, and still maintain those expectations of myself today (here I am now, working on this blog at 5:43 am).

The Gen Xers on my team were even more surprised by the quiet quitting trend than I was. Their take was that you have to do what it takes to get ahead. It’s taboo for many Gen Xers to leave before the boss. They are used to working longer hours, with less “work life balance” than me, filling their off time with volunteer roles and second jobs.

The Gen Zers on my team crave the work/life balance we all hear about in the news. Rather than throwing themselves headfirst into grind culture, they want to make sure that they have time for their life outside of the office. If they are going to show up early and work late, they want to know that it's for a purpose they believe in and it’s directly related to accelerating their career growth and increase their salaries.

Reaching an Understanding

When I look around my office (and by office, I mean Zoom tiles), I think about how a lot of offices around the world look similar to mine. The workforce will always be a blend of people from different generations, each shaped by their own experience. We’re all adjusting to new styles of work. No matter what generation you come from, or what generation you’re managing, you’ll get stronger results from your team if you set clear expectations, check your generational bias, and understand the perspective of others.

What does this look like in action?

Here are three steps you can take to encourage and inspire your team to put their hearts into what they do:

1. Show appreciation for your team.

If an employee is making $50,000, explain that value back to them. What does their work mean to the overall organization? How does their wage and work contribute to the vision and overall goals of the company? By showing your team their value and reminding them that what they do has a purpose, you can inspire each team member to stay engaged in their work.

2. Embrace flexible work schedules and trust your team.

Let Gen Z innovate, do their thing and find their own way of getting work done. At the same time, communicate: outline clear KPIs, let them know what you expect, and give feedback along the way. Remember, part of an employee feeling a sense of purpose in their job is knowing that they are learning and growing. The more engaged you are in their development and show respect for their time, the more engaged your team will be in following through. And if they don’t meet expectations, have an open, honest conversation with them while still embracing their preferred work style.

3. Help your employees better prioritize their work.

Leverage available tools and resources to find efficiencies while you’re developing your team. Make sure that your processes are well-documented and easy to understand, and encourage the team to contribute ideas and better tools if they have them. Remind them that there’s an open door if they have any questions.

At the end of the day, our job as leaders in an organization is to keep our teams boldly engaged. By helping our employees find purpose in their work, we can build stronger teams that are less likely to be swayed by the latest trend, and more likely to stay focused on their jobs because they care.

------

Allie Danziger is the co-founder of Ampersand, an online training platform for businesses and professionals looking to level up their talent.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston space company lands latest NASA deal to advance lunar logistics

To The Moon

Houston-based space exploration, infrastructure, and services company Intuitive Machines has secured about $2.5 million from NASA to study challenges related to carrying cargo on the company’s lunar lander and hauling cargo on the moon. The lander will be used for NASA’s Artemis missions to the moon and eventually to Mars.

“Intuitive Machines has been methodically working on executing lunar delivery, data transmission, and infrastructure service missions, making us uniquely positioned to provide strategies and concepts that may shape lunar logistics and mobility solutions for the Artemis generation,” Intuitive Machines CEO Steve Altemus says in a news release.

“We look forward to bringing our proven expertise together to deliver innovative solutions that establish capabilities on the [moon] and place deeper exploration within reach.”

Intuitive Machines will soon launch its lunar lander on a SpaceX Falcon 9 rocket to deliver NASA technology and science projects, along with commercial payloads, to the moon’s Mons Mouton plateau. Lift-off will happen at NASA’s Kennedy Space Center in Florida within a launch window that starts in late February. It’ll be the lander’s second trip to the moon.

In September, Intuitive Machines landed a deal with NASA that could be worth more than $4.8 billion.

Under the contract, Intuitive Machines will supply communication and navigation services for missions in the “near space” region, which extends from the earth’s surface to beyond the moon.

The five-year deal includes an option to add five years to the contract. The initial round of NASA funding runs through September 2029.

Play it back: Houston home tech startup begins 2025 with fresh funding

HOUSTON INNOVATORS PODCAST EPISODE 272

One of the dozen or so Houston startups kicking of the new year with fresh funding is SmartAC.com, a company that's designed a platform that enables contractors in the HVAC and plumbing industries to monitor, manage, and optimize their maintenance memberships through advanced sensors, AI-driven diagnostics, and proactive alerts.

Last month, the SmartAC.com raised a follow-on round with support from local investor Mercury to continue growth and expansion of the product, which has evolved on many ways since the company launched in 2020, emerging from stealth with $10 million raised in a series A. In a May 2023 interview for the Houston Innovators Podcast, Founder and CEO Josh Teekell explained how he embraced the power of a pivot.

The company's sensors can monitor all aspects of air conditioning units and report back any issues, meaning homeowners have quicker and less costly repairs. While SmartAC.com started with providing the service and tech to homeowners directly, Teekell says he's had a greater interest in working with plumbers and HVAC companies who then deploy the technology to their customers.

"It became quite evident that homeowners don't care about air conditioning really at all until their system breaks," Teekell says on the show. "The technology is really built around giving those contractors as another way to gain a customer relationship and keep it."

Revisit the podcast episode below where Teekell talks about SmartAC.com's last raise.

SmartAC.com's previous round in 2023 — a $22 million series B — was used grow its team that goes out to deploy the technology and train the contractors on the platform.

"We've been very fortunate to get some of the biggest names in Houston on our cap table," Teekell says in the May 2023 conversation. "Since we're raising a bunch of money locally, everyone understands what a pain air conditioning can be."

Houston biotech company tests hard-to-fight cancer therapeutics

fighting cancer

A Houston-based, female-founded biotech company has developed a treatment that could prove to be an effective therapy for a rare blood cancer.

Cellenkos Therapeutics has completed promising Phase 1b testing of its Treg cell therapy, CK0804, in the fight against myelofibrosis. According to a news release from the Cellenkos team, the use of its cord-blood-derived therapeutics could signal a paradigm shift for the treatment of this hard-to-fight cancer.

Cellenkos was founded by MD Anderson Cancer Center physician and professor Simrit Parmar. Her research at the hospital displayed the ability of a unique subset of T cells’ capability to home in on a patient’s bone marrow, restoring immune balance, and potentially halting disease progression.

Myelofibrosis has long been treated primarily with JAK (Janus Kinase) inhibitors, medications that help to block inflammatory enzymes. They work by suppressing the immune response to the blood cancer, but don’t slow the progression of the malady. And they’re not effective for every patient.

“There is a significant need for new therapeutic options for patients living with myelofibrosis who have suboptimal responses to approved JAK inhibitors,” Parmar says. “We are greatly encouraged by the safety profile and early signs of efficacy observed in this patient cohort and look forward to continuing our evaluation of the clinical potential of CK0804 in our planned expansion cohort.”

The expansion cohort is currently enrolling patients with myelofibrosis. What exactly are sufferers dealing with? Myelofibrosis is a chronic disease that causes bone marrow to form scar tissue. This makes it difficult for the body to produce normal blood cells, leaving patients with fatigue, spleen enlargement and night sweats.

Myelofibrosis is rare, with just 16,000 to 18,500 people affected in the United States. But for patients who don’t respond well to JAKs, the prognosis could mean a shorter span than the six-year median survival rate outlined for the disease by Cleveland Clinic.

Helping myelofibrosis patients to thrive isn’t the only goal for Cellenkos right now.

The company seeks to aid people with rare conditions, particularly inflammatory and autoimmune disorders, with the use of CK0804, but also other candidates including one known as CK0801. The latter drug has shown promising efficacy in aplastic anemia, including transfusion independence in treated patients.

The company closed its $15 million series A round led by BVCF Management, based in Shanghai, in 2021. Read more here.